Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10648
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSartor, Daniela Men
dc.contributor.authorVerberne, Anthony J Men
dc.date.accessioned2015-05-16T00:10:14Z
dc.date.available2015-05-16T00:10:14Z
dc.date.issued2008-07-12en
dc.identifier.citationBrain Research Reviews 2008; 59(1): 140-54en
dc.identifier.govdoc18656498en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/10648en
dc.description.abstractIt is generally accepted that the gastrointestinal circulation is primarily under the control of the enteric nervous system. However, recent studies have demonstrated that the sympathetic nervous system may play a greater role in postprandial gastrointestinal circulatory function than was thought previously. Cholecystokinin (CCK) is a gastrointestinal hormone released from enteroendocrine cells lining the intestinal mucosa in response to feeding. Systemic administration of CCK induces gastrointestinal vasodilation mediated by withdrawal of sympathetic vasomotor drive. CCK differentially influences the discharge rate of presympathetic vasomotor neurons in the rostral ventrolateral medulla and this response is mirrored by differential responses in the gastrointestinal and skeletal muscle sympathetic vasomotor outflows. CCK1 receptors located on abdominal vagal afferent neurons are activated by CCK which, in turn, activates an intramedullary circuit in a manner analogous to that of other sympathetic cardiovascular reflexes. Evidently, abdominal vagal afferent neurons influence sympathetic vasomotor discharge in a fashion that contrasts markedly with changes in sympathetic vasomotor outflow and regional circulatory function produced by activation of vagal cardiopulmonary reflexes. The clinical implications of this mechanism may extend to the treatment of disorders such as postprandial hypotension and gastrointestinal diseases that are contingent on local blood flow.en
dc.language.isoenen
dc.subject.otherAnimalsen
dc.subject.otherCardiovascular System.drug effects.metabolismen
dc.subject.otherCholecystokinin.metabolismen
dc.subject.otherEfferent Pathways.physiologyen
dc.subject.otherGastrointestinal Tract.drug effects.metabolismen
dc.subject.otherHumansen
dc.subject.otherMedulla Oblongata.anatomy & histology.physiologyen
dc.subject.otherSignal Transduction.physiologyen
dc.subject.otherVagus Nerve.physiologyen
dc.titleAbdominal vagal signalling: a novel role for cholecystokinin in circulatory control?en
dc.typeJournal Articleen
dc.identifier.journaltitleBrain Research reviewsen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne Clinical Pharmacology and Therapeutics Unit, Austin Health, Heidelberg Victoria, 3084 Australiaen
dc.identifier.doi10.1016/j.brainresrev.2008.07.002en
dc.description.pages140-54en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/18656498en
dc.type.austinJournal Articleen
local.name.researcherVerberne, Anthony J M
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptClinical Pharmacology and Therapeutics-
crisitem.author.deptMedicine (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

74
checked on Feb 6, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.